Quotient Therapeutics

Series-B+
quotient-tx.com Biotech & Healthcare Cambridge, United States Founded 2022 51-100
Total Funding $50M
Latest Round $50M Series-B+
Last Announced Nov 22, 2023
Investors 1 Backer
Decision Makers 6 Verified

About Quotient Therapeutics

Discover how Quotient is pioneering a new field of genetics with somatic genomics to unveil a universe of genetic information and develop new therapies.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United States
Year Founded 2022
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website quotient-tx.com
Domain Registered Date May 23, 2023

Social & Network Presence

X / Twitter Profile @QuotientTx (298 followers) Created on Aug 2023
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $50,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    X account created (@QuotientTx)

    298 followers

  3. Milestone

    Website domain registered

    quotient-tx.com

  4. Milestone

    Company founded

    Cambridge, United States

Investors & Backers

1
Flagship Pioneering

Funding History

1 Round
Series-B+ · Nov 22, 2023

Founders & Leadership

4

Geoffrey von Maltzahn

Founder

Work email & phone locked Unlock →

Peter Campbell

CSO & Academic Cofounder

Work email & phone locked Unlock →

Rahul Kakkar

President and Chief Executive Officer

Work email & phone locked Unlock →

Susan Keefe

Chief Financial Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts